These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16148834)

  • 1. Biological and artificial liver support system in children: a new perspective.
    Mazariegos G; Chen Y; Squires R
    Pediatr Crit Care Med; 2005 Sep; 6(5):616-7. PubMed ID: 16148834
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver support for fulminant hepatic failure: is it time to use the molecular adsorbents recycling system in children?
    Tissières P; Sasbón JS; Devictor D
    Pediatr Crit Care Med; 2005 Sep; 6(5):585-91. PubMed ID: 16148822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single Pass Albumin Dialysis-A Dose-Finding Study to Define Optimal Albumin Concentration and Dialysate Flow.
    Schmuck RB; Nawrot GH; Fikatas P; Reutzel-Selke A; Pratschke J; Sauer IM
    Artif Organs; 2017 Feb; 41(2):153-161. PubMed ID: 27121702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present status and prospect for artificial liver support system].
    Li LJ; Huang JR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):453-4. PubMed ID: 12939171
    [No Abstract]   [Full Text] [Related]  

  • 5. Correction of disturbed pathophysiology of hepatic failure by albumin dialysis.
    Williams R
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):19-24. PubMed ID: 18234633
    [No Abstract]   [Full Text] [Related]  

  • 6. Modular extracorporeal liver support.
    Sauer IM; Gerlach JC
    Artif Organs; 2002 Aug; 26(8):703-6. PubMed ID: 12139497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: Results of a pivotal pre-clinical study.
    Lee KC; Baker LA; Stanzani G; Alibhai H; Chang YM; Jimenez Palacios C; Leckie PJ; Giordano P; Priestnall SL; Antoine DJ; Jenkins RE; Goldring CE; Park BK; Andreola F; Agarwal B; Mookerjee RP; Davies NA; Jalan R
    J Hepatol; 2015 Sep; 63(3):634-42. PubMed ID: 25937432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MARS liver dialysis in children with acute liver failure.
    Da Costa M; Lee MK; Lee HL; Aw M; Lee KH; Phua KB; Prabhakaran K; Quak SH
    Ann Acad Med Singap; 2004 Sep; 33(5 Suppl):S73-4. PubMed ID: 15651219
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis in albumin dialysis: are we really ready for it?
    Stange J
    Liver Transpl; 2004 Sep; 10(9):1107-8. PubMed ID: 15350000
    [No Abstract]   [Full Text] [Related]  

  • 10. Artificial liver support devices as treatment option for liver failure.
    Nevens F; Laleman W
    Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):17-26. PubMed ID: 22482522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equipment review: the molecular adsorbents recirculating system (MARS).
    Boyle M; Kurtovic J; Bihari D; Riordan S; Steiner C
    Crit Care; 2004 Aug; 8(4):280-6. PubMed ID: 15312211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular adsorbent recirculating system and bioartificial devices for liver failure.
    Bañares R; Catalina MV; Vaquero J
    Clin Liver Dis; 2014 Nov; 18(4):945-56. PubMed ID: 25438293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of therapeutic albumin solutions used for molecular adsorbent recirculating system-based liver dialysis.
    De Bruyn T; Meijers B; Evenepoel P; Laub R; Willems L; Augustijns P; Annaert P
    Artif Organs; 2012 Jan; 36(1):29-41. PubMed ID: 21955219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The evaluation for principles and clinical application of combined artificial liver therapy].
    GUO LM
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):326-7. PubMed ID: 19497192
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: the molecular adsorbents recirculating system (MARS) in liver failure.
    Sen S; Mookerjee RP; Davies NA; Williams R; Jalan R
    Aliment Pharmacol Ther; 2002 Dec; 16 Suppl 5():32-8. PubMed ID: 12423451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary evaluation on the effects of a hybrid bioartificial liver support system in the treatment of hepatic failure].
    Wang YJ; He NH; Niu RZ; Liu J; Wen HW; Li JJ; Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):461-3. PubMed ID: 12939175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bioartificial liver that combines plasma dialysis and whole liver perfusion.
    Umehara M; Totsuka E; Ishizawa Y; Nara M; Hakamada K; Umehara Y; Sasaki M
    Hepatogastroenterology; 2008; 55(85):1216-21. PubMed ID: 18795660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review.
    Kjaergard LL; Liu J; Als-Nielsen B; Gluud C
    JAMA; 2003 Jan; 289(2):217-22. PubMed ID: 12517233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular adsorbent recirculating system: albumin dialysis-based extracorporeal liver assist device.
    Kapoor D
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S280-6. PubMed ID: 12472950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of MARS® dialysis in acute-on-chronic liver failure].
    Mitzner S
    Z Gastroenterol; 2013 Oct; 51(10):1193-4. PubMed ID: 24122382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.